Cardlytics, Inc. Stock News

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Cardlytics  between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247...

Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2024 Results Conference Call March 12, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Luke Horton - Northland Securities Kyle Peterson - Needham Cal Bartyzal - Craig-Hallum Robert Coolbrith - Evercore ISI Operator Good af...

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2024. "While 2024 was a challenging year for Cardlytics, we nevertheless planted the seeds and refocused our efforts to get back on track for growth this year," said Amit Gupta, CEO of Cardlytics. "We remain grounded in our vision for long-term and ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options

NEW YORK , March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330...